Clinical Trial Update: The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation

View source ↗

Summary

A clinical trial evaluating how frailty affects adverse outcomes after cardiopulmonary resuscitation in patients requiring code blue activation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Frailty Syndrome
• Respiratory Arrest

Snippet

Sponsor: Umraniye Education and Research Hospital | Conditions: Cardiac Arrest, Frailty | Status: RECRUITING